|Articles|December 1, 2012

Atypical antipsychotics may raise LUTS risk in women

Women taking atypical antipsychotic medications (AAPs) have about a 3-fiold higher prevalence of lower urinary tract symptoms (LUTS) compared with nonusers, a study on the presence of LUTS among users of psychoactive medications has found.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe

Related Content

PMOS Awareness Month: Watch our expert panel discussion on PMOS

ByJoshua Fitch, Senior Editor

September 9th 2026

Kevin Ault, MD, on the clinician's role in maternal COVID-19 vaccine counseling

ByKevin Ault, MD

September 9th 2026

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

ByJoshua Fitch, Senior Editor

September 9th 2026

Amber Watters, MD, on anesthesia in external cephalic version for breech presentation

ByAmber Watters, MD, MS

September 8th 2026

David Shalowitz, MD, on cross-specialty collaboration to expand salpingectomy access

ByDavid I. Shalowitz, MD, MSHP

September 8th 2026

Latest CME

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 4-5, 2026

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Atypical antipsychotics may raise LUTS risk in women

Related Content

PMOS Awareness Month: Watch our expert panel discussion on PMOS

Kevin Ault, MD, on the clinician's role in maternal COVID-19 vaccine counseling

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

Amber Watters, MD, on anesthesia in external cephalic version for breech presentation

David Shalowitz, MD, on cross-specialty collaboration to expand salpingectomy access

Latest CME

Join Us at The Pathology Meeting in Las Vegas

Join Us at The Pathology Meeting in Las Vegas

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Trending on Contemporary OB/GYN

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

PMOS Awareness Month: Watch our expert panel discussion on PMOS

Kevin Ault, MD, on the clinician's role in maternal COVID-19 vaccine counseling

Positively Pregnant tool helps patients time home pregnancy testing

Amber Watters, MD, on anesthesia in external cephalic version for breech presentation